MedWatch

EU won't take up option to buy more Astrazeneca vaccines

The EU has opted out of buying more vaccine doses from Astrazeneca and instead plans to buy vaccines from Pfizer/Biontech, since the latter company has better met the demands of its contract, and since its vaccine type has less severe side effects than those possibly connected with the Astrazeneca vaccine.

Photo: CHRISTOF STACHE/AFP / AFP

BRUXELLES

The EU will not be making use of its contractual option to buy 100 million more vaccine doses from Astrazeneca, according to an EU spokesman for the EU Commission at a press conference in Bruxelles.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Latest news

See all jobs